Personalized cancer medicines have quadrupled in the last two decades and by 2026 there will be an estimated 20M cancer survivors in the U.S. Next week on 1114 were discussing the future of these medicines. For more on PeopleVCancer visit httpb

Personalized cancer medicines have quadrupled in the last two decades and by 2026 there will be an estimated 20M cancer survivors in the U.S. Next week on 11/14, we’re discussing the future of these medicines. For more on #PeopleVCancer, visit http://b

Personalized cancer medicines have quadrupled in the last two decades and by 2026 there will be an estimated 20M cancer survivors in the U.S. Next week on 11/14, we’re discussing the future of these medicines. For more on #PeopleVCancer, visit http://bit.ly/2RKJKlK  #GoBoldly pic.twitter.com/oGpTUB1Fi9

More From BioPortfolio on "Personalized cancer medicines have quadrupled in the last two decades and by 2026 there will be an estimated 20M cancer survivors in the U.S. Next week on 11/14, we’re discussing the future of these medicines. For more on #PeopleVCancer, visit http://b"